Drugs / ALK Alutard birch pollen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03394508 | Jan 2013 → Dec 2017 | allergic disease, asthma, rhinitis | Karolinska Institutet | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALK Alutard birch pollen | “ALK Alutard birch pollen or ALK Alutard grass pollen” NCT03394508 ↗ |
| Known as | ALK Alutard birch | “ALK Alutard birch or 5-grasses” NCT03394508 ↗ |
| Modality | Other / unclassified | “allergen-specific immunotherapy” NCT03394508 ↗ |